Literature DB >> 9226732

Modulating effects of a cold water stimulus on opioid effects in volunteers.

K M Conley1, A Y Toledano, J L Apfelbaum, J P Zacny.   

Abstract

The purpose of this study was to characterize the effect of a painful stimulus on morphine and butorphanol effects in healthy non-drug abusing volunteers. Thirteen subjects with no history of opiate dependence participated in a randomized, placebo-controlled, double-blind, crossover trial in which each subject received saline, 2 mg/70 kg butorphanol, and 10 mg/70 kg morphine, IV, in each of two conditions, periodic forearm immersions into either ice-cold water (2 degrees C) or into warm water (37 degrees C). Both opioids reduced self-reported ratings of pain intensity, indicative of analgesia. Several of the subjective effects of morphine were attenuated either during or in between cold-water immersions, including visual analog scale ratings of "coasting (spaced out)," "high (drug "high")," "sleepy (drowsy, tired)," and "lightheaded". In contrast, some of butorphanol's subjective effects were increased by the cold-water manipulation. Morphine impaired psychomotor performance during one of the warm-water immersions, but not during the cold-water immersions. Psychomotor impairment induced by butorphanol was not affected by water temperature. This study provides evidence that opioid effects can be modulated by a painful stimulus in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226732     DOI: 10.1007/s002130050298

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Opioid treatment of experimental pain activates nuclear factor-κB.

Authors:  Peggy Compton; Charles Griffis; Elizabeth Crabb Breen; Matthew Torrington; Ryan Sadakane; Eshetu Tefera; Michael R Irwin
Journal:  J Opioid Manag       Date:  2015 Mar-Apr

2.  Effects of cold pressor pain on the abuse liability of intranasal oxycodone in male and female prescription opioid abusers.

Authors:  Michelle R Lofwall; Paul A Nuzzo; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2011-12-30       Impact factor: 4.492

3.  Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.

Authors:  Ziva D Cooper; Gillinder Bedi; Divya Ramesh; Rebecca Balter; Sandra D Comer; Margaret Haney
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

4.  Effects of morphine on thermal sensitivity in adult and aged rats.

Authors:  Drake Morgan; Jeremiah D Mitzelfelt; Lorraine M Koerper; Christy S Carter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

Review 5.  Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.

Authors:  Ziva D Cooper; Donald I Abrams
Journal:  Am J Drug Alcohol Abuse       Date:  2019-11-05       Impact factor: 3.829

6.  Sex-dependent effects of cannabis-induced analgesia.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Drug Alcohol Depend       Date:  2016-08-05       Impact factor: 4.492

7.  Effects of stress on responses to methamphetamine in humans.

Authors:  Anna Söderpalm; Lilia Nikolayev; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

8.  Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.

Authors:  Ziva D Cooper; Sandra D Comer; Margaret Haney
Journal:  Neuropsychopharmacology       Date:  2013-04-22       Impact factor: 7.853

9.  Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers.

Authors:  Sandra D Comer; Ziva D Cooper; William J Kowalczyk; Maria A Sullivan; Suzette M Evans; Adam M Bisaga; Suzanne K Vosburg
Journal:  Psychopharmacology (Berl)       Date:  2009-10-27       Impact factor: 4.530

10.  Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone.

Authors:  Jermaine D Jones; Mudassir Mumtaz; Jeanne M Manubay; Shanthi Mogali; Elliana Sherwin; Suky Martinez; Sandra D Comer
Journal:  Pharmacol Biochem Behav       Date:  2019-09-04       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.